Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
RVMD	REVOLUTION MEDICINES INC	$8.21B	-41.80%	-35.60%	-36.16%	-43.60%	0.30	11.79	N/A	N/A	N/A
SLXN	SILEXION THERAPEUTICS CORP	$2.69M	N/A	-301.70%	-305.76%	-389.00%	47.31	2.44	N/A	N/A	N/A
OPK	OPKO HEALTH INC	$1.15B	-13.20%	-8.30%	-1.95%	-3.90%	0.52	3.41	32.70%	-26.70%	-5.29%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$720.12M	-63.00%	-18.80%	-19.35%	-25.00%	1.61	5.16	29.10%	-90.20%	-74.15%
KPTI	KARYOPHARM THERAPEUTICS INC	$56.80M	N/A	-84.30%	-1,390.78%	-39.60%	-1.44	0.99	96.40%	-90.00%	-57.38%
MNMD	MIND MEDICINE (MINDMED) INC	$811.86M	-50.20%	-39.40%	-48.51%	-120.40%	0.43	4.98	N/A	N/A	N/A
ROIV	ROIVANT SCIENCES LTD	$10.36B	-10.10%	-8.70%	-9.14%	-12.90%	0.05	40.54	96.30%	-2,111.80%	-1,935.92%
IOBT	IO BIOTECH INC	$104.09M	-281.80%	-169.30%	-458.40%	2,120.10%	25.59	1.96	N/A	N/A	N/A
GOVX	GEOVAX LABS INC	$16.38M	-408.80%	-279.90%	-878.76%	27,511.10%	0.90	2.03	N/A	N/A	N/A
IMUX	IMMUNIC INC	$89.97M	-326.90%	-181.30%	1,898.68%	558.80%	-4.88	0.74	N/A	N/A	N/A
EVH	EVOLENT HEALTH INC	$1.05B	-19.10%	-7.30%	-6.72%	-18.30%	1.49	1.01	16.40%	-8.40%	-5.83%
ABOS	ACUMEN PHARMACEUTICALS INC	$86.01M	-81.40%	-62.00%	-90.14%	-68.60%	0.47	5.97	N/A	N/A	N/A
CAPR	CAPRICOR THERAPEUTICS INC	$324.13M	-62.70%	-50.80%	-66.53%	-84.30%	0.27	4.37	100.00%	-522.50%	-522.51%
PRAX	PRAXIS PRECISION MEDICINES INC	$1.10B	-60.10%	-54.80%	-62.10%	-103.50%	0.12	6.31	100.00%	-3,232.60%	-3,232.61%
ATOS	ATOSSA THERAPEUTICS INC	$110.96M	-42.80%	-39.50%	-49.78%	10,558.10%	0.12	9.17	N/A	N/A	N/A
ZYXI	ZYNEX INC	$43.93M	-122.60%	-26.10%	-166.79%	-21.40%	67.15	0.62	75.40%	-19.80%	-13.91%
WVE	WAVE LIFE SCIENCES LTD	$1.08B	-78.40%	-41.50%	-78.74%	302.50%	0.76	2.56	100.00%	-138.20%	-138.24%
DYN	DYNE THERAPEUTICS INC	$1.87B	-64.10%	-56.80%	-60.04%	-163.20%	0.28	16.83	N/A	N/A	N/A
KAPA	KAIROS PHARMA LTD	$22.82M	-88.70%	-74.20%	-78.36%	-202.30%	0.11	7.16	N/A	N/A	N/A
GUTS	FRACTYL HEALTH INC	$67.39M	-596.40%	-105.00%	-248.34%	-118.80%	-4.41	1.22	58.80%	-586,864.70%	-586,864.71%
SAVA	CASSAVA SCIENCES INC	$144.44M	-93.30%	-74.90%	-139.88%	2,577.00%	0.54	2.43	N/A	N/A	N/A
ENGN	ENGENE HOLDINGS INC	$332.23M	-39.90%	-34.20%	-40.52%	-44.20%	0.22	10.34	N/A	N/A	N/A
BIAF	BIOAFFINITY TECHNOLOGIES INC	$5.02M	-930.20%	-200.10%	-535.24%	-892.70%	-3.22	0.65	29.90%	-152.20%	-150.71%
MDCX	MEDICUS PHARMA LTD	$46.86M	-549.40%	-228.10%	-491.82%	1,512.90%	2.67	1.29	N/A	N/A	N/A
IMVT	IMMUNOVANT INC	$2.83B	-84.50%	-75.40%	-73.22%	4,175.70%	0.09	12.32	N/A	N/A	N/A
CRDF	CARDIFF ONCOLOGY INC	$137.04M	-78.00%	-63.70%	-86.37%	-119.30%	0.29	4.42	100.00%	-9,348.50%	-9,344.14%
RCKT	ROCKET PHARMACEUTICALS INC	$351.77M	-66.00%	-56.80%	-67.64%	-86.60%	0.19	6.39	N/A	N/A	N/A
VERA	VERA THERAPEUTICS INC	$1.80B	-46.70%	-39.50%	-38.68%	-39.70%	0.24	17.03	N/A	N/A	N/A
ETHZ	ETHZILLA CORP	$15.16M	-264.20%	-151.00%	-176.08%	266.90%	0.99	0.58	N/A	N/A	N/A
REPL	REPLIMUNE GROUP INC	$318.37M	-58.00%	-45.20%	-48.87%	-54.70%	0.33	7.95	N/A	N/A	N/A
QSI	QUANTUM-SI INC	$301.72M	-47.60%	-42.20%	-46.17%	-50.70%	0.15	9.43	53.20%	-3,120.10%	-3,117.58%
VKTX	VIKING THERAPEUTICS INC	$2.88B	-20.00%	-19.40%	-21.55%	-20.80%	0.04	25.86	N/A	N/A	N/A
VVOS	VIVOS THERAPEUTICS INC	$23.41M	-232.80%	-84.30%	-73.04%	-246.70%	4.68	1.05	55.90%	-99.50%	-99.49%
OSTX	OS THERAPIES INC	$65.38M	N/A	-294.50%	-201.89%	459.40%	0.72	1.03	N/A	N/A	N/A
CGEM	CULLINAN THERAPEUTICS INC	$351.73M	-29.70%	-28.40%	-32.34%	-34.60%	0.05	11.62	N/A	N/A	N/A
ATYR	ATYR PHARMA INC	$74.85M	-86.90%	-64.80%	-73.26%	-74.00%	0.30	7.80	N/A	N/A	N/A
MGNX	MACROGENICS INC	$109.35M	-40.20%	-14.60%	-16.70%	-37.80%	4.26	5.26	86.90%	-22.00%	-20.84%
CRVO	CERVOMED INC	$72.06M	-44.10%	-40.60%	-53.91%	-56.50%	0.11	9.78	100.00%	-200.60%	-200.58%
CYBN	CYBIN INC	$134.97M	-55.60%	-49.90%	-62.63%	-489.50%	0.39	9.87	N/A	N/A	N/A
APDN	APPLIED DNA SCIENCES INC	$5.35M	-681.60%	-522.00%	-166.93%	-1,287.60%	0.41	2.77	39.60%	-2,047.40%	-399.87%
MYO	MYOMO INC	$35.19M	-50.90%	-27.00%	-32.95%	-59.10%	1.20	2.39	69.20%	-22.90%	-21.76%
CABA	CABALETTA BIO INC	$119.75M	-78.30%	-65.70%	-95.86%	-545.60%	0.36	3.96	N/A	N/A	N/A
PRFX	PAINREFORM LTD	$2.05M	-321.90%	-201.80%	-704.42%	1,140.50%	1.48	1.81	N/A	N/A	N/A
BCYC	BICYCLE THERAPEUTICS PLC	$512.48M	-25.10%	-20.90%	-25.14%	-491.60%	0.19	14.86	100.00%	-790.10%	-807.73%
CLDX	CELLDEX THERAPEUTICS INC	$1.74B	-23.50%	-22.40%	-25.28%	-25.10%	0.05	21.67	100.00%	-2,366.10%	-2,366.07%
FBLG	FIBROBIOLOGICS INC	$24.04M	-609.20%	-101.20%	-448.93%	-1,214.30%	15.17	0.93	N/A	N/A	N/A
SKYE	SKYE BIOSCIENCE INC	$127.36M	-68.70%	-62.50%	-96.93%	-501.30%	0.19	6.09	N/A	N/A	N/A
JSPR	JASPER THERAPEUTICS INC	$40.15M	-172.30%	-128.30%	-350.16%	1,606.10%	0.98	2.10	N/A	N/A	N/A
AGL	AGILON HEALTH INC	$451.72M	-64.60%	-16.90%	-66.40%	-88.50%	3.19	1.16	-1.80%	-5.30%	-5.22%
DRIO	DARIOHEALTH CORP	$30.19M	-88.70%	-52.60%	-44.65%	-153.60%	0.69	3.30	55.00%	-219.20%	-162.13%
LNSR	LENSAR INC	$145.63M	-777.70%	-86.20%	-123.60%	-176.80%	-3.67	1.81	47.90%	-99.20%	-99.16%
DYAI	DYADIC INTERNATIONAL INC	$39.81M	-355.30%	-60.70%	-113.79%	-79.20%	-16.36	2.02	59.90%	-134.80%	-123.19%
ADXN	ADDEX THERAPEUTICS LTD	$7.03M	83.20%	75.30%	103.14%	119.50%	0.14	3.03	100.00%	3,521.70%	3,530.71%
ANEB	ANEBULO PHARMACEUTICALS INC	$98.60M	-90.10%	-84.50%	-53.97%	-2,138.00%	0.04	25.29	N/A	N/A	N/A
XBIO	XENETIC BIOSCIENCES INC	$4.78M	-54.50%	-47.30%	-69.28%	3,722.20%	0.20	5.93	100.00%	-126.00%	-126.03%
LEXX	LEXARIA BIOSCIENCE CORP	$20.54M	-149.40%	-133.70%	-216.83%	-2,073.30%	0.28	3.90	99.60%	-1,849.40%	-1,849.39%
AKTX	AKARI THERAPEUTICS PLC	$63.27M	-78.00%	-31.60%	-35.44%	83.00%	0.99	0.19	N/A	N/A	N/A
KZR	KEZAR LIFE SCIENCES INC	$26.73M	-63.50%	-52.10%	-73.19%	-72.50%	0.19	7.29	N/A	N/A	N/A
KLRS	KALARIS THERAPEUTICS INC	$104.92M	-50.00%	-40.20%	-49.88%	1,705.00%	0.75	11.98	N/A	N/A	N/A
ABP	ABPRO HOLDINGS INC	$17.48M	N/A	-628.00%	65.76%	84.40%	-1.17	0.15	100.00%	-12,282.00%	-6,089.62%
EPRX	EUPRAXIA PHARMACEUTICALS INC	$206.41M	-123.50%	-118.40%	-138.38%	13,065.60%	0.12	8.72	N/A	N/A	N/A
KPRX	KIORA PHARMACEUTICALS INC	$7.94M	-42.80%	-32.20%	-34.24%	-46.30%	0.44	5.14	100.00%	-60,257.30%	-49,209.99%
XCUR	EXICURE INC	$24.07M	-110.00%	-41.10%	-34.76%	-79.40%	0.82	2.91	N/A	N/A	N/A
JAGX	JAGUAR HEALTH INC	$4.68M	-530.10%	-76.80%	-215.16%	-107.80%	5.18	0.96	81.90%	-344.20%	-347.06%
IVA	INVENTIVA SA	$578.76M	N/A	-195.40%	5,384.47%	-342.30%	-2.12	0.92	100.00%	-1,251.00%	-645.04%
IRIX	IRIDEX CORP	$19.54M	-187.30%	-17.40%	-30.22%	-39.50%	4.21	1.96	39.50%	-11.00%	-10.86%
FORA	FORIAN INC	$68.45M	-3.10%	-1.80%	-1.31%	-1.10%	0.57	2.66	59.30%	-3.60%	-1.62%
ANL	ADLAI NORTYE LTD	$63.40M	-98.90%	-51.50%	-192.69%	-828.00%	1.80	1.41	N/A	N/A	N/A
APLM	APOLLOMICS INC	$20.34M	-233.70%	-157.30%	-937.36%	2,070.90%	1.69	1.39	N/A	N/A	N/A
INDP	INDAPTUS THERAPEUTICS INC	$3.86M	-612.60%	-243.80%	1,013.62%	1,268.40%	-5.09	0.75	N/A	N/A	N/A
INCR	INTERCURE LTD	$68.86M	-15.90%	-8.80%	-6.19%	-7.70%	0.92	1.73	12.70%	-28.40%	-13.88%
YDES	YD BIOPHARMA LTD	$1.12B	N/A	-12.30%	-20.99%	401.50%	0.04	13.18	30.40%	-276.60%	-271.52%
YCBD	CBDMD INC	$5.56M	-184.40%	-45.20%	-24.47%	-253.70%	0.62	N/A	61.20%	-25.50%	-8.12%
XWEL	XWELL INC	$5.99M	N/A	-77.70%	-148.43%	-94.40%	-3.54	1.25	20.50%	-67.60%	-62.91%
IGC	IGC PHARMA INC	$36.32M	-97.40%	-70.20%	-101.99%	-164.10%	0.31	1.25	46.00%	-477.90%	-477.92%
XTNT	XTANT MEDICAL HOLDINGS INC	$83.40M	-10.10%	-4.70%	0.16%	0.10%	1.13	2.47	60.20%	-3.60%	0.09%
XRTX	XORTX THERAPEUTICS INC	$3.03M	-73.50%	-53.00%	-92.63%	-383.60%	0.35	1.78	N/A	N/A	N/A
IPHA	INNATE PHARMA SA	$154.75M	-271.40%	-37.70%	-65.09%	-71.60%	17.07	2.21	100.00%	-364.40%	-327.14%
BBOT	BRIDGEBIO ONCOLOGY THERAPEUTICS INC	$714.87M	N/A	-58.10%	-85.89%	-63.50%	-0.13	5.22	N/A	N/A	N/A
HBIO	HARVARD BIOSCIENCE INC	$19.77M	-144.20%	-55.00%	-215.53%	-104.70%	4.09	0.82	56.90%	-64.70%	-60.45%
ADAP	ADAPTIMMUNE THERAPEUTICS PLC	$39.04M	N/A	-79.70%	-202.70%	-112.90%	-2.84	1.52	94.70%	-260.80%	-246.42%
GNTA	GENENTA SCIENCE SPA	$57.80M	-54.10%	-48.00%	-70.04%	-71.10%	0.19	6.89	N/A	N/A	N/A
GNFT	GENFIT SA	$177.51M	-51.70%	-18.80%	-13.83%	-17.70%	3.13	3.74	100.00%	-85.40%	-53.34%
WHWK	WHITEHAWK THERAPEUTICS INC	$91.39M	26.20%	22.50%	12.50%	111.70%	0.06	18.95	88.70%	99.40%	99.77%
XTLB	XTL BIOPHARMACEUTICALS LTD	$10.31M	-26.80%	-18.70%	-18.24%	911.00%	0.57	0.61	0.70%	-227.70%	-256.54%
AMS	AMERICAN SHARED HOSPITAL SERVICES	$18.88M	-9.70%	-3.90%	-3.23%	-2.40%	1.42	1.17	24.40%	-8.30%	-4.71%
GELS	GELTEQ LTD	$13.21M	N/A	N/A	N/A	N/A	0.34	0.79	N/A	N/A	N/A
VYNE	VYNE THERAPEUTICS INC	$8.46M	-77.60%	-63.10%	-99.12%	-137.10%	0.15	7.60	100.00%	-8,097.70%	-8,096.85%
CPHI	CHINA PHARMA HOLDINGS INC	$6.10M	-52.80%	-26.00%	-41.53%	-58.30%	1.13	0.51	-20.50%	-83.20%	-80.46%
IMRN	IMMURON LTD	$11.32M	-50.30%	-40.70%	-63.80%	-160.50%	0.26	5.09	71.00%	-60.00%	-59.88%
VRNA	VERONA PHARMA PLC	$9.20B	-38.70%	-16.60%	-6.85%	-12.50%	1.06	10.71	95.20%	-36.60%	-16.12%
FEMY	FEMASYS INC	$9.81M	-392.40%	-137.10%	-564.70%	-201.20%	5.65	0.93	66.20%	-1,242.60%	-1,142.11%
ATHA	ATHIRA PHARMA INC	$15.22M	-139.40%	-106.80%	-183.80%	-4,338.00%	0.11	10.81	N/A	N/A	N/A
VRAX	VIRAX BIOLABS GROUP LTD	$2.66M	-109.60%	-101.80%	-108.73%	-324.80%	0.17	7.27	-838.20%	-95,739.20%	-98,816.73%
EXOZ	EXOZYMES INC	$129.83M	-134.40%	-81.60%	-94.44%	-255.30%	0.34	6.19	N/A	N/A	N/A
ETNB	89BIO INC	$2.15B	-81.40%	-70.20%	-58.76%	-105.30%	0.13	18.03	N/A	N/A	N/A
INM	INMED PHARMACEUTICALS INC	$5.22M	-93.20%	-74.50%	-56.70%	-384.90%	0.16	6.99	34.50%	-165.10%	-157.62%
BEAT	HEARTBEAM INC	$57.30M	-448.00%	-325.20%	-486.47%	-3,426.40%	0.43	2.98	N/A	N/A	N/A
ERNA	ERNEXA THERAPEUTICS INC	$8.74M	N/A	-682.30%	-780.58%	-703.90%	0.71	1.81	112.30%	-8,959.00%	-7,890.57%
VIVS	VIVOSIM LABS INC	$8.35M	-33.00%	-21.40%	-20.06%	-143.80%	0.26	4.52	97.90%	-1,399.30%	-1,389.44%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	634	+1.79%	+1.91%	+6.43%	-34.10%	-103.63x	4.74x	-110.35%	-7.14%	-11.38%	+74.80%	Strong Buy
Diagnostics & Research	56	+1.01%	-2.91%	-2.11%	-20.34%	20.19x	3.68x	-3.05%	+7.21%	+15.74%	+12.47%	Strong Buy
Drug Manufacturers - General	19	+1.12%	-2.43%	-1.22%	-11.24%	36.82x	5.90x	+60.33%	+10.39%	+17.87%	+44.86%	Buy
Drug Manufacturers - Specialty & Generic	76	+0.80%	-1.60%	+0.72%	-14.92%	-26.18x	2.19x	+11.47%	+4.52%	+9.99%	+34.64%	Buy
Healthcare Plans	11	+0.51%	+2.09%	+1.67%	-31.43%	14.69x	2.04x	+15.83%	+4.97%	+11.53%	+16.07%	Buy
Health Information Services	53	+1.70%	-0.25%	-0.80%	-51.95%	79.61x	4.19x	+8.45%	+5.32%	+9.21%	+27.22%	Strong Buy
Medical Care Facilities	47	+1.83%	+4.11%	+3.99%	-27.10%	16.54x	5.02x	-187.08%	+6.89%	+15.30%	+13.48%	Buy
Medical Devices	142	+0.34%	-2.25%	-5.08%	-29.83%	30.11x	3.93x	+13.92%	+8.58%	+10.09%	+31.97%	Strong Buy
Medical Distribution	10	+2.95%	+6.64%	+8.45%	+42.42%	28.76x	311.71x	-10.64%	+3.09%	+19.03%	+11.15%	Buy
Medical Instruments & Supplies	55	+1.38%	-1.61%	-4.20%	-63.95%	29.83x	3.29x	+10.52%	+8.43%	+11.16%	+28.03%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Sep 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #1 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: B.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 14 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 74.57% over the past year, overperforming other healthcare stocks by 108 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 82.42% from Theravance Biopharma's current stock price of $14.07.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #2 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 35, which is 10 points higher than the healthcare sector average of 25. It passed 12 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -4.34% over the past year, overperforming other healthcare stocks by 29 percentage points.

Embecta has an average 1 year price target of $18.50, an upside of 33.09% from Embecta's current stock price of $13.90.

Embecta stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Embecta, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Infusystem Holdings (NYSEMKT:INFU)

Infusystem Holdings (NYSEMKT:INFU) is the #3 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Infusystem Holdings (NYSEMKT:INFU) is: Value: C, Growth: B, Momentum: B, Sentiment: A, Safety: C, Financials: A, and AI: C.

Infusystem Holdings (NYSEMKT:INFU) has a Due Diligence Score of 29, which is 4 points higher than the healthcare sector average of 25. It passed 9 out of 33 due diligence checks and has average fundamentals. Infusystem Holdings has seen its stock return 57.62% over the past year, overperforming other healthcare stocks by 91 percentage points.

Infusystem Holdings has an average 1 year price target of $13.50, an upside of 30.56% from Infusystem Holdings's current stock price of $10.34.

Infusystem Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Infusystem Holdings, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 14.55%, which is 12 percentage points higher than the healthcare sector average of 2.08%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

2. Cryo Cell International (NYSEMKT:CCEL)

Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of 8.33%, which is 6 percentage points higher than the healthcare sector average of 2.08%.

Cryo Cell International's dividend payout ratio of -2,166.7% indicates that its high dividend yield might not be sustainable for the long-term.

3. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 7.89%, which is 6 percentage points higher than the healthcare sector average of 2.08%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 1.36% in the last day, and up 0.15% over the last week. Bioaffinity Technologies was the among the top gainers in the healthcare sector, gaining 55.13% yesterday.

bioAffinity Technologies shares are trading lower after the company priced a $4.8M public offering of ~1.92M shares or pre-funded warrants at $2.50 per share.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -30.86% in the past year. It has overperformed other stocks in the healthcare sector by 2 percentage points.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -4.34% in the past year. It has overperformed other stocks in the healthcare sector by 29 percentage points.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 27 points higher than the healthcare sector average of 16. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 89.06% in the past year. It has overperformed other stocks in the healthcare sector by 122 percentage points.

Are healthcare stocks a good buy now?

52.17% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 40.4% over the next year.

5.3% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.13% of healthcare stocks are rated B (Buy), 46.64% are rated C (Hold), 24.62% are rated D (Sell), and 11.31% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 7.98x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Embecta (NASDAQ:EMBC)

3. Infusystem Holdings (NYSEMKT:INFU)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Dominari Holdings (NASDAQ:DOMH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Embecta (NASDAQ:EMBC)

3. Infusystem Holdings (NYSEMKT:INFU)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Dominari Holdings (NASDAQ:DOMH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.